203
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated in silico approaches

, , , , , , , , & show all
Pages 5349-5361 | Received 28 Aug 2019, Accepted 25 Nov 2019, Published online: 18 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shweta Sharma, Shubham Srivastav, Garima Singh, Smrita Singh, Ruchi Malik, Mohammad Mumtaz Alam, Mohammad Shaqiquzamman, Shakir Ali & Mymoona Akhter. (2021) In silico strategies for probing novel DPP-IV inhibitors as anti-diabetic agents. Journal of Biomolecular Structure and Dynamics 39:6, pages 2118-2132.
Read now

Articles from other publishers (3)

Shweta Sharma, Mohd. Hafizur Rehman Ansari, Kalicharan Sharma, Rajesh K Singh, Shakir Ali, Mohd. Mumtaz Alam, Mohd. Shaqiquzamman Zaman, Prawez Alam & Mymoona Akhter. (2023) Pyrazoline scaffold: hit identification to lead synthesis and biological evaluation as antidiabetic agents. Future Medicinal Chemistry 15:1, pages 9-24.
Crossref
Reema Abu Khalaf, Maha Awad, Luay Al-Essa, Sara Mefleh, Dima Sabbah, Eveen Al-Shalabi & Ihsan Shabeeb. (2021) Discovery, synthesis and in combo studies of Schiff’s bases as promising dipeptidyl peptidase-IV inhibitors. Molecular Diversity 26:2, pages 1213-1225.
Crossref
Virendra Nath, Manish Ramchandani, Neeraj Kumar, Rohini Agrawal & Vipin Kumar. (2021) Computational identification of potential dipeptidyl peptidase (DPP)-IV inhibitors: Structure based virtual screening, molecular dynamics simulation and knowledge based SAR studies. Journal of Molecular Structure 1224, pages 129006.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.